Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23.

Michels E, Hoebeeck J, De Preter K, Schramm A, Brichard B, De Paepe A, Eggert A, Laureys G, Vandesompele J, Speleman F.

BMC Cancer. 2008 Jun 17;8:173. doi: 10.1186/1471-2407-8-173.

2.

Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma.

Nowacki S, Skowron M, Oberthuer A, Fagin A, Voth H, Brors B, Westermann F, Eggert A, Hero B, Berthold F, Fischer M.

Oncogene. 2008 May 22;27(23):3329-38. Epub 2007 Dec 17.

PMID:
18084322
3.

Positional and functional mapping of a neuroblastoma differentiation gene on chromosome 11.

De Preter K, Vandesompele J, Menten B, Carr P, Fiegler H, Edsjö A, Carter NP, Yigit N, Waelput W, Van Roy N, Bader S, Påhlman S, Speleman F.

BMC Genomics. 2005 Jul 6;6:97.

4.

Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.

Ando K, Ohira M, Ozaki T, Nakagawa A, Akazawa K, Suenaga Y, Nakamura Y, Koda T, Kamijo T, Murakami Y, Nakagawara A.

Int J Cancer. 2008 Nov 1;123(9):2087-94. doi: 10.1002/ijc.23776.

5.

Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.

Ejeskär K, Krona C, Carén H, Zaibak F, Li L, Martinsson T, Ioannou PA.

BMC Cancer. 2005 Dec 16;5:161.

6.

Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q.

McArdle L, McDermott M, Purcell R, Grehan D, O'Meara A, Breatnach F, Catchpoole D, Culhane AC, Jeffery I, Gallagher WM, Stallings RL.

Carcinogenesis. 2004 Sep;25(9):1599-609. Epub 2004 Apr 16. Review.

PMID:
15090470
7.

Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.

Guo C, White PS, Weiss MJ, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM, Maris JM.

Oncogene. 1999 Sep 2;18(35):4948-57.

8.

EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.

Alaminos M, Dávalos V, Ropero S, Setién F, Paz MF, Herranz M, Fraga MF, Mora J, Cheung NK, Gerald WL, Esteller M.

Cancer Res. 2005 Apr 1;65(7):2565-71.

9.

No evidence for involvement of SDHD in neuroblastoma pathogenesis.

De Preter K, Vandesompele J, Hoebeeck J, Vandenbroecke C, Smet J, Nuyts A, Laureys G, Combaret V, Van Roy N, Roels F, Van Coster R, Praet M, De Paepe A, Speleman F.

BMC Cancer. 2004 Aug 24;4:55.

10.

Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q.

Fischer M, Bauer T, Oberthür A, Hero B, Theissen J, Ehrich M, Spitz R, Eils R, Westermann F, Brors B, König R, Berthold F.

Oncogene. 2010 Feb 11;29(6):865-75. doi: 10.1038/onc.2009.390. Epub 2009 Nov 9.

PMID:
19901960
11.

A 2-Mb sequence-ready contig map and a novel immunoglobulin superfamily gene IGSF4 in the LOH region of chromosome 11q23.2.

Gomyo H, Arai Y, Tanigami A, Murakami Y, Hattori M, Hosoda F, Arai K, Aikawa Y, Tsuda H, Hirohashi S, Asakawa S, Shimizu N, Soeda E, Sakaki Y, Ohki M.

Genomics. 1999 Dec 1;62(2):139-46.

PMID:
10610705
12.

Molecular analysis of the putative tumour-suppressor gene EXTL1 in neuroblastoma patients and cell lines.

Mathysen D, Van Roy N, Van Hul W, Laureys G, Ambros P, Speleman F, Wuyts W.

Eur J Cancer. 2004 May;40(8):1255-61.

PMID:
15110891
13.

Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours.

Ejeskär K, Sjöberg RM, Abel F, Kogner P, Ambros PF, Martinsson T.

Med Pediatr Oncol. 2001 Jan;36(1):61-6.

PMID:
11464908
14.

Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression.

Mosse YP, Diskin SJ, Wasserman N, Rinaldi K, Attiyeh EF, Cole K, Jagannathan J, Bhambhani K, Winter C, Maris JM.

Genes Chromosomes Cancer. 2007 Oct;46(10):936-49.

PMID:
17647283
15.

Cell adhesion molecule 1 is a novel pancreatic-islet cell adhesion molecule that mediates nerve-islet cell interactions.

Koma Y, Furuno T, Hagiyama M, Hamaguchi K, Nakanishi M, Masuda M, Hirota S, Yokozaki H, Ito A.

Gastroenterology. 2008 May;134(5):1544-54. doi: 10.1053/j.gastro.2008.01.081. Epub 2008 Feb 10.

PMID:
18471525
16.

Expression of APITD1 is not related to copy number changes of chromosomal region 1p36 or the prognosis of uveal melanoma.

van Gils W, Mensink HW, Kilic E, Vaarwater J, Verbiest MM, Paridaens D, Luyten GP, de Klein A, Brüggenwirth HT.

Invest Ophthalmol Vis Sci. 2007 Nov;48(11):4919-23.

PMID:
17962439
17.

Identification of tumor suppressor candidate genes by physical and sequence mapping of the TSLC1 region of human chromosome 11q23.

Pletcher MT, Nobukuni T, Fukuhara H, Kuramochi M, Maruyama T, Sekiya T, Sussan T, Isomura M, Murakami Y, Reeves RH.

Gene. 2001 Aug 8;273(2):181-9.

PMID:
11595164
18.

Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.

Wang Q, Diskin S, Rappaport E, Attiyeh E, Mosse Y, Shue D, Seiser E, Jagannathan J, Shusterman S, Bansal M, Khazi D, Winter C, Okawa E, Grant G, Cnaan A, Zhao H, Cheung NK, Gerald W, London W, Matthay KK, Brodeur GM, Maris JM.

Cancer Res. 2006 Jun 15;66(12):6050-62.

19.

Functional localization of a melanoma tumor suppressor gene to a small (< or = 2 Mb) region on 11q23.

Robertson GP, Goldberg EK, Lugo TG, Fountain JW.

Oncogene. 1999 May 20;18(20):3173-80.

20.

Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma.

White PS, Thompson PM, Gotoh T, Okawa ER, Igarashi J, Kok M, Winter C, Gregory SG, Hogarty MD, Maris JM, Brodeur GM.

Oncogene. 2005 Apr 14;24(16):2684-94.

PMID:
15829979

Supplemental Content

Support Center